1. Home
  2. IDT vs ATAI Comparison

IDT vs ATAI Comparison

Compare IDT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

N/A

Current Price

$50.82

Market Cap

1.2B

ML Signal

N/A

ATAI

ATAI Life Sciences N.V.

N/A

Current Price

$4.13

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDT
ATAI
Founded
1990
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
IDT
ATAI
Price
$50.82
$4.13
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$15.57
AVG Volume (30 Days)
106.9K
4.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$308,000.00
Revenue This Year
$1.99
N/A
Revenue Next Year
N/A
$285.00
P/E Ratio
$15.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.35
$1.15
52 Week High
$71.12
$6.73

Technical Indicators

Market Signals
Indicator
IDT
ATAI
Relative Strength Index (RSI) 57.57 56.68
Support Level $50.02 $3.42
Resistance Level $52.24 $4.46
Average True Range (ATR) 1.09 0.28
MACD 0.17 0.01
Stochastic Oscillator 69.59 72.39

Price Performance

Historical Comparison
IDT
ATAI

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Share on Social Networks: